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SUMMARY:
Healthcare-associated infections are infections caused
by a wide variety of common and unusual bacteria, fungi, and
viruses during the course of receiving medical care.  Medical
advances have brought lifesaving care to patients in need,
yet many of those advances come with a risk of healthcare-
associated infection. These infections related to medical care
can be devastating and even deadly. As the ability to prevent
healthcare-associated infections grows, these infections are
increasingly unacceptable.
Recent successes in healthcare-associated infections
elimination have been very encouraging. Examples include
sustained reduction in central line-associated bloodstream
infections by 70%, simply by ensuring adherence to available
guidelines. Reductions have been demonstrated for other
helthcare-associated infections as well, but, much more
remains to be done.
Wherever patient care is provided, adherence to
infection prevention guidelines is needed to ensure that all
care is safe care. This includes traditional hospital settings
as well as outpatient surgery centers, long-term care facilities,
rehabilitation centers, and community clinics.
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The health sector is a high-risk area because adverse
events, arising from treatment rather than disease, can lead
to death, serious damage, complications and patient suffering.
Although many hospitals and healthcare settings have
procedures in place to ensure patient safety, the health care
sector still lags behind other industries and services that have
introduced systematic safety processes.
A number of investigations from all over the world
have underlined the need for and the possibility of reducing
the number of adverse events in the health sector.
 The health sector should be designed in a way that
errors and adverse events are prevented, detected or
contained so that serious errors are avoided and compliance
with safety procedures is enhanced.
Health sector induced harm to patients imposes a
heavy burden on society. Investment in patient safety
therefore has the potential to generate savings in expenditure
coupled with an obvious benefit to patients.
Patient safety refers to mechanisms that prevent or
mitigate patient harm stemming from healthcare processes.
Patients’ safety can be compromised due to medical errors,
namely when patients receive wrong medication, are
improperly treated, or when test results are incorrect or
delayed. A major aspect to patient safety is the avoidance of
healthcare-related infections.
The European Commission estimates that in the EU:
· 1 in 10 patients are affected by healthcare-related
infections;
· 3 million deaths are caused by healthcare-related
infections;
· 50,000 people die each year of healthcare-related
infections.
In addition, almost half of all preventable adverse
events in the EU are a consequence of medical errors.  In 2006,
the Directorate-General of Health and Consumer Protection
launched Eurobarometer survey on medical errors. According
to the Commission’s Eurobarometer survey: 
· 23% of all respondents have experienced a medical
error in some form;
· 18% of all respondents have experienced a serious
medical error in a local hospital (i.e. they have either suffered
personally or have family members who have suffered one);
· 11% of all respondents have suffered from a serious
medical error from a medicine that was prescribed.
The majority of respondents believe that medical
errors are a prominent problem in Europe. Most Europeans
trust professional healthcare workers, and attribute overall
responsibility to national healthcare systems. Many of the
respondents recognised that patients themselves play an
important role with respect to avoiding medical errors. They
believe that good communication channels between the
healthcare worker and the patient is crucial.  
Healthcare errors are more prevalent in countries that
have weak healthcare systems. A lack of training of healthcare
workers, time constraints on healthcare workers, and
insufficient reporting and learning systems to prevent errors
in the future, are the main causes of insufficient patient safety.
The World Health Organisation has launched a World
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challenge and avoid healthcare-associated infections. In
order to prevent these, a high level of hygiene is essential,
which includes:
· Clean hands;
· Clean practices;
· Clean products;
· Clean environment;
· Clean equipment.
In addition, there are a number of innovative
technologies that increase patient safety:  
· Safety of blood transfusions: in Europe,
approximately 1.3 million blood platelet transfusions are
performed annually. Despite the introduction of blood
screening and testing measures, patients remain at risk of
infection and transfusion-associated reactions because
micro-organisms such as viruses, bacteria and parasites can
be present in blood and blood products (and remain
“invisible”). New medical technologies such as pathogen
inactivation technologies have been developed that can
considerably improve the safety of blood products.
· Cross infections: the “single use” medical devices
have been developed in response to the need to avoid cross
infection and thus to increase standards of care. These range
from simple devices such as syringes, surgical drapes and
surgical gowns to more complex technologies such as biopsy
forceps and balloon catheters.
· Use of safety features: in general, the use of safety
features including alarms, programs, automatic identification
technology in medical equipment increases the safety of
patients.
Infection in hospitals and other healthcare settings is
a problem for health services around the world and is
receiving considerable media and political attention. Health
care interventions, although intended to benefit patients, may
in some cases cause harm. Healthcare associated infection
affects an estimated one in ten hospital patients each year.
Infections caused by these agents are often difficult to treat
due to antimicrobial resistance and difficult to eradicate from
the health care environment and may spread to the
community.
· Hospital-acquired infections are a major contributor
to morbidity and mortality:
o 1 out of 10 hospitalised patients in Europe contracts
a nosocomial (hospital-acquired) infection,
o 150 persons die in Europe every day due to a hospital
acquired infection.
· Hospital acquired infections are a burden on
Healthcare costs:
o Annihilating the results of advanced and expensive
medical treatment,
o Increasing the length of hospital stay by 8 days on
average per affected patient,
o Thereby adding more than 10 million unnecessary
patient days in hospitals in Europe per year.
· An increasing proportion of bacteria have become
unaffected by common antibiotic treatment regimens. This
phenomenon is called “antimicrobial resistance”. Resistant
strains are much more frequent among healthcare associated
infections. They are difficult to treat, their treatment is very
expensive and they result in a higher patient mortality than
susceptible strains.
The most common problem strains are:
o Methicillin Resistant Staph aureus (MRSA),
o Vancomycin Resistant Enterococci (VRE) and
o Enterobacteriaceae with an Extended Spectrum Beta
Lactamase.
· Active surveillance cultures and screening is needed
to prevent nosocomial infections. Detecting the unrecognized
MRSA-colonised or VRE-colonised patients helps to prevent
transmission and infections.
· An active infection control program of patients and
personnel, including surveillance cultures, admission
screening and contact isolation in addition to hygiene
measures, has proven to significantly reduce both the number
of infections and hospitalization costs.
· Active surveillance cultures to identify e.g. MRSA
carriers are justified and efficient from a medical and
economical standpoint, leading to significant cost savings for
healthcare systems and society.
· Active surveillance programs are successful: e.g.
The Netherlands, Denmark and Finland have succeeded in
controlling healthcare-related infections and in stabilizing
resistance rates.
Focus on patient safety leads to savings in treating
patients exposed to adverse events and the consequential
improved use of financial resources. In addition, savings are
achieved in administration costs associated with complaints
and applications for compensation. Most importantly, patient
safety contributes to an increase in quality of life. In order to
achieve this, the culture of safety can be improved
significantly in various ways.
The 2005 Luxembourg declaration on Patient Safety
recognizes that access to high quality healthcare is a key
human right recognised and valued by the EU, its Institutions
and the citizens of Europe. The “open method of
coordination” for healthcare and long-term care proposed by
the Commission provides a framework for Member States to
exchange experience and to compare policies and
performance.
Decision 2119/98/EC1 of the European Parliament and
of the Council established a Network for the epidemiological
surveillance and control of communicable diseases in the
1 Decision No 2119/98/EC of the European Parliament and of
the Council of 24 September 1998 setting up a network for the
epidemiological surveillance and control of communicable diseases
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Community and Decision 2000/96/EC2 provided that
surveillance of healthcare-related infections within this
Community network will be performed by standardised
collection and analysis of data in a way that will be determined
when specific Community surveillance networks are put in
place. Under the public health programme3 projects are
financed addressing the problem of healthcare associated
infections and preparing the establishment of such a
Community surveillance network.
Healthcare-related infections prolong the suffering of
the patients, increase health care costs and have other direct
and indirect economic implications, such as loss of
productivity and disability.
Although measurement of costs is difficult, the cost
of hospital acquired infection is high, for example the UK
National Audit Office estimated it at £1 billion per year for
the UK. Costs will be different for other countries and will
change with time, however the relative magnitudes will be
similar. Overall in the European Union, it has been estimated
that there are approximately 3 million healthcare associated
infections and 50,000 attributable deaths per year. The US
Institute of Medicine estimates that preventable adverse
patient events, including hospital-acquired infections, are
responsible for 44,000-98,000 deaths annually in the US at a
cost of $17-$29 billion4.
Although healthcare-related infections is a
multifaceted problem ways to control it are understood and
assessment of the cost of control programmes shows major
savings can be achieved. The Study on the Efficiency of
Nosocomial Infection Control5 estimated that the cost of
infection control teams was only 7% of the infection costs.
In Europe, some Member States like the UK and France
have passed legislation that obliges hospitals to report
publicly certain indicators related to healthcare-associated
infections.
In the Netherlands, a Court ruling decided that data
on incidence of healthcare-associated infections collected
through a national surveillance system do not have to be
made public. Surveillance of post-operative infections,
however, is recognised as one of the quality indicators of
hospitals and may be made public in the future.
Reported rates of healthcare-associated infections
show large variations across the Member States of the
European Union reflecting large differences in surveillance
methodology, the functioning of the health services and the
adoption of policies, guidelines and technologies. Therefore
the interpretation of these figures has to be undertaken with
great care and needs expert consultation. National surveillance
systems, therefore, should be clear on regulation of data
access and should comply with the data protection
regulations and guarantee the confidentiality and security of
data.
Confidential treatment of the identity of healthcare
institutions participating to a surveillance network should be
encouraged in order to foster the validity of reported data
and to prevent possible misinterpretation of data. Serious
efforts and resources are needed to improve reporting
systems and make data more comparable.
Health care-associated infections affect hundreds of
millions of people each year worldwide. No health-care
system is spared. The WHO World Alliance for Patient Safety
has chosen the prevention of health care-associated infection
as the first Global Patient Safety Challenge. Success relies
more on the willingness of human nature to change and
accept changes than on systems and economic constraints.
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